Clinical Trials Directory

Trials / Completed

CompletedNCT02402296

Host Modulatory Effects of β-glucan on Localized Aggressive Periodontitis

Efficacy of β-glucan in Treatment of Localized Aggressive Periodontitis: A Short Term Double-blinded, Placebo-controlled, Randomized Clinical Trial

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
30 (actual)
Sponsor
Al-Azhar University · Academic / Other
Sex
All
Age
20 Years – 27 Years
Healthy volunteers
Not accepted

Summary

combining the non-surgical therapy with a well-tolerated substance that can stimulate protective immune responses like B-glucan, might effectively mount resolution pathways contributing to resolving of the chronic lesion observed in aggressive forms of periodontal disease.

Detailed description

Aim: To investigate the efficacy of β-glucan supplementation to non-surgical periodontal therapy in localized aggressive periodontitis (LAP) patients. Method: 30 subjects were randomly and equally assigned to receive scaling and root planing; either with placebo pills (Group I) or β-glucan (100 mg/once a day) (Group II), for 40 days. Subjects were clinically monitored on day 0 and day 91. Gingival samples were harvested from hopeless teeth sites to be investigated histologically and immunohistochemically using matrix metalloproteinase (MMP)-1 and 9 antibodies form each patient; at the same time intervals.

Conditions

Interventions

TypeNameDescription
DRUGβ-1,3/1,6-D-glucan15 patients (in group II) suffering from localized aggressive periodontitis followed a strict plaque control program (within two weeks); followed by a systemic course of β-1,3/1,6-D-glucan oral supplementation for 40 days.
OTHERPlacebo15 patients (in group I) suffering from localized aggressive periodontitis followed a strict plaque control program (within two weeks); followed by a systemic course of placebo capsules oral supplementation for 40 days.

Timeline

Start date
2013-01-01
Primary completion
2014-06-01
Completion
2014-08-01
First posted
2015-03-30
Last updated
2015-06-09
Results posted
2015-06-09

Source: ClinicalTrials.gov record NCT02402296. Inclusion in this directory is not an endorsement.